PHARMACODYNAMICALLY OPTIMIZED ERYTHROPOIETIN TREATMENT COMBINED WITH PHLEBOTOMY REDUCTION PREDICTED TO ELIMINATE BLOOD TRANSFUSIONS IN SELECTED PRETERM INFANTS

BACKGROUND: Preterm very low birth weight (VLBW) infants weighing <1.5 kg at birth develop anemia requiring red blood cell transfusions (RBCTx). Because laboratory blood loss is a primary cause of anemia leading to RBCTx in VLBW infants, our goal was to simulate the extent to which RBCTx can be r...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pediatr Res
Auteurs principaux: Rosebraugh, Matthew R., Widness, John A., Nalbant, Demet, Cress, Gretchen, Veng-Pedersen, Peter
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4418561/
https://ncbi.nlm.nih.gov/pubmed/24216541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pr.2013.213
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires